# OnCo record swog-s0809 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/swog-s0809/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "swog-s0809", "NCT00789958" ;
  schema:name "SWOG S0809"@en ;
  schema:description "The only prospective trial of chemotherapy followed by chemoradiotherapy after surgery for bile duct and gallbladder cancer: 79 patients, a third with gallbladder cancer, had two-year survival of 65 percent and median survival of 35 months, similar whether or not the margin was clear. It is the basis on which some centres offer radiotherapy after an R1 resection."@en ;
  schema:url <https://onco.cc/trials/swog-s0809/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00789958>, <https://doi.org/10.1200/JCO.2014.60.2219>, <https://doi.org/10.1245/s10434-024-15117-y> ;
  onco:status "completed" ;
  onco:phase "2" ;
  onco:related <https://onco.cc/trials/bilcap/>, <https://onco.cc/trials/polcagb/> ;
  onco:cancers <https://onco.cc/cancers/gallbladder/>, <https://onco.cc/cancers/extrahepatic-cholangiocarcinoma/>, <https://onco.cc/cancers/cholangiocarcinoma/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/capecitabine/> ;
  onco:institutions <https://onco.cc/institutions/swog/> ;
  onco:terms <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/terms/radiotherapy/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-swog-s0809-adjuvant-chemoradiation-jco-2015/>, <https://onco.cc/key-papers/paper-wang-adjuvant-chemoradiotherapy-nomogram-gallbladder-cancer-jco-2011/> .